+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-04-27Number of Pages: 102

Separation Systems for Commercial Biotechnology Market (Liquid chromatography, membrane filters, electrophoresis instruments, flow cytometer instruments, centrifugation systems, DNA microarray instruments, protein microarray instruments, MACS & FACS systems, biochips, lab-on-a-chip, Life Sciences Research and Diagnostics, Pharmaceuticals, Food & Cosmetics, Energy, and Agriculture) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Separation systems play a vital role in industrial biotechnology processes. These systems produce the desired products from small to large quantities and has wide area of applications. Liquid chromatography, membrane filters, flow cytometer instruments, centrifugation systems, and electrophoresis instruments are the major segments of the market. Each of the systems uses different method to carry out separations in the biotechnology, bio-pharmaceutical, agriculture, energy industries, etc.

The global Separation systems market for Commercial Biotechnology is anticipated to grow at a significant rate during the forecast period due to technological advancements, increasing awareness through conferences and exhibition, rising support and participation of government agencies, investment in R&D, and increase in number of biotechnology firms.

Chromatography systems have gained widespread popularity due to the introduction of novel technologies in chromatographic instruments and consumables. Flow cytometry has emerged as a leading, application-rich technology. Increasing demand and advancement of microarray technology boosts market growth. Laboratory automation has enabled scientists to process samples at low cost, and thus has played a major role in the experiments. Increasing number of conferences in the U.S., Europe, and Asia-Pacific is aiming to spread the new and upcoming innovations in the separation systems market. Growing awareness about chromatography has induced government organizations in the U.S., Europe, and Asia-Pacific to increase their investments, grants, and funds for the development of chromatography. Some of the market restrains includes high cost of systems and technologies, lack of innovation in electrophoresis equipment technology, and patent rights over MACS technique.

The global separation systems for commercial biotechnology market has been estimated based on product type, end-user, and geography. Based on product type, the global market has been segmented into liquid chromatography, membrane filters, electrophoresis instruments, flow-cytometer instruments, centrifugation systems, DNA microarray instruments, protein microarray instruments, MACS & FACS systems, and others. The liquid chromatography systems segment held the largest share of the market in 2014. The segment is likely to continue to dominate the market during the forecast period. Based on end-user, the separation systems market has been segmented into life sciences research and diagnostics, pharmaceuticals, food & cosmetics, energy, and agriculture.

The life sciences research and diagnostics end-user segment held the largest share of the market in 2014. The segment is anticipated to continue to dominate the market during the forecast period. It is also expected to record the fastest growth from 2015 to 2023. Rising number of genomic and proteomic researches in the life sciences research segment has increased demand for separation systems.

Geographically, the separation systems market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). North America held the largest share of the ultrasound devices market in 2014, followed by Europe. Asia Pacific was identified as the third largest market for ultrasound devices in 2014. The market in the region is expected to expand at a low CAGR during the forecast period. The reason for low market revenue and growth in North America is due to the high usage of other imaging technologies. 

Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare, and Merck KGaA are the major players operating in the global separation systems for commercial biotechnology market. Danaher Corporation is the leading player in the market.

separation-systems-commercial-biotechnology-market

 

Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Separation Systems for Commercial Biotechnology Market Overview 
3.1 Market Definition and Overview
3.2 Future Market Trends
3.3 Event Impact Analysis
3.4 Market Dynamics
     3.4.1 Drivers
            3.4.1.1 Technological advancements
            3.4.1.2 Increasing awareness through conferences and exhibitions
            3.4.1.3 Rising support and participation of government agencies
            3.4.1.4 Investment in R&D and increase in number of biotechnology firms
     3.4.2 Restraints
            3.4.2.1 High cost of systems and technologies
            3.4.2.2 Lack of innovation in electrophoresis equipment technology
            3.4.2.3 Patent rights over MACS technique
     3.4.3 Opportunities
            3.4.3.1 Emerging economies with improving health care infrastructure and high disposable income
            3.4.3.2 Strong research and development activities
            3.4.3.3 Targeted therapy and personalized medicine spurs microarray industry
3.5 Market Attractiveness Analysis of the Global Separation Systems for Commercial Biotechnology Market, by Geography, 2014
3.6 Competitive Landscape
     3.6.1 Market Share Analysis, by Key Players, 2014 (Value %)

Chapter 4 Global Separation Systems for Commercial Biotechnology Market Revenue, Product Type, (US$ Mn), 2015–2023
4.1 Global Separation Systems for Commercial Biotechnology Market Revenue, by Product Type, 2013–2023, (US$ Mn)

Chapter 5 Global Separation Systems for Commercial Biotechnology Market Revenue, by End-user, (US$ Mn), 2015–2023
5.1 Global Separation Systems for Commercial Biotechnology Market Revenue, by End User, 2013–2023, (US$ Mn)

Chapter 6 Global Separation Systems for Commercial Biotechnology Market Revenue, By Geography, (US$ Mn), 2015–2023
6.1 Global Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.2 North America Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.3 Europe Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.4 Asia Pacific Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.5 Rest of World Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4  Business Strategies
8.1.5 Recent Development
8.2 Danaher Corporation
8.3 Becton, Dickinson and Company
8.4 Bio-Rad Laboratories, Inc.
8.5 GE Healthcare
8.6 Merck KGaA
8.7 PerkinElmer, Inc.
8.8 QIAGEN
8.9 Thermo Fisher Scientific, Inc.
8.10 Waters Corporation
8.11 Others

List of Figures

FIG. 1 Global Separation Systems for Commercial Biotechnology Market, by End-user, (US$ Mn), 2014
FIG. 2 Global Separation Systems for Commercial Biotechnology Market, by End User, (US$ Mn), 2014
FIG. 3 Porter’s Five Forces Analysis: Global Separation Systems for Commercial Biotechnology Market
FIG. 4 Market Attractiveness Analysis: Global Separation Systems for Commercial Biotechnology Market
FIG. 5 Global Separation Systems for Commercial Biotechnology Market, by Key Players, 2014 (%)
FIG. 6 Affymetrix, Inc.: Financial Overview: (US$ Mn), 2012–2014
FIG. 7 Becton, Dickinson and Company: Financial Overview: (US$ Mn), 2012–2014
FIG. 8 Bio-Rad Laboratories, Inc.: Financial Overview: (US$ Mn), 2012–2014
FIG. 9 Danaher Corporation: Financial Overview: (US$ Mn), 2012–2014
FIG. 10 Danaher Corporation: Financial Overview: (US$ Mn), 2012–2014
FIG. 11 GE Healthcare: Financial Overview: (US$ Mn), 2012–2014
FIG. 12 PerkinElmer, Inc.: Financial Overview: (US$ Mn), 2012–2014
FIG. 13 QIAGEN N.V.: Financial Overview: (US$ Mn), 2012–2014
FIG. 14 Thermo Fisher Scientific, Inc.: Financial Overview: (US$ Mn), 2012–2014
FIG. 15 Waters Corporation: Financial Overview: (US$ Mn), 2012–2014

List of Tables

Table 1. Separation Systems for Commercial Biotechnology Market: Market Snapshot
Table 2. Global Separation Systems for Commercial Biotechnology Market Revenue, by Product Type, (US$ Mn), 2013–2023
Table 3. Global Separation Systems for Commercial Biotechnology Market Revenue, by End user, (US$ Mn), 2013–2023
Table 4. Global Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
Table 5. North America Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
Table 6. Europe Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
Table 7. Asia Pacific Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)
Table 8. Rest of World Separation Systems for Commercial Biotechnology Market Revenue, by Geography, 2013–2023 (US$ Mn)

Separation systems are used in a wide range of commercial applications in the biotechnology industry. This report on the separation systems for commercial biotechnology market analyses the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global separation systems market with respect to the leading market segments based on type of product, technology, and geography.

The global separation systems commercial biotechnology market was valued at US$ 10,665.5 Mn in 2014. The wide area of application of the Separation systems in Biotechnology and Biopharmaceutical Industry will lead the market to rise at a 6.8% CAGR from 2015 to 2023.

Some of the factors that are driving the global separation systems commercial biotechnology market are: Technological advancements, Investment in R&D and increase in number of biotechnology firms.

The market overview section of the report includes qualitative analysis of the overall separation systems commercial biotechnology market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and increase their shares in the global market.

The global separation systems commercial biotechnology market has been segmented based on product type, end-user, and geography. Based on product type, the separation systems market has been categorized into two major segments: liquid chromatography, membrane filters, electrophoresis instruments, flow cytometer instruments, centrifugation systems, DNA microarray instruments, protein microarray instruments, MACS & FACS systems, others (biochips, lab-on-a-chip, etc.). Based on application, the separation systems market has been segmented into five applications: life sciences research and diagnostics, pharmaceuticals, food & cosmetics, energy, and agriculture. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.

Geographically, the separation systems market commercial biotechnology has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe includes Germany, the U.K., and Rest of Europe. Asia Pacific comprises China, Japan, and Rest of Asia Pacific. Rest of the World comprises of Latin America, Middle East & Africa. The recommendations section included in the report would assist existing players to increase their market shares and new companies to establish their presence in the separation systems market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare and Merck KGaA.

The global separation systems for commercial biotechnology market has been segmented as follows:

Global Separation Systems for Commercial Biotechnology Market, by Product Type

  • Centrifugation Systems
  • Liquid Chromatography
  • Electrophoresis Units
  • Membrane Filters
  • Flow Cytometry
  • DNA Microarray
  • Protein Microarray
  • MACS & FACS Systems
  • Others (biochips, lab-on-a-chip, etc.)

Global Separation Systems for Commercial Biotechnology Market, by End User

  • Life Sciences Research
  • Pharmaceuticals
  • Food & Cosmetics
  • Agriculture
  • Energy

Global Separation Systems for Commercial Biotechnology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa


 
 
Back To Top